Ingalin is shown as a part of complex treatment of acute respiratory diseases of the upper airways, pharyngitises, tracheitises, bronchitis, pneumonia.

Structure

Active ingredients: 1 bottle contains menthol 0.284 g, an eucalyptus of tincture of 14.28 ml;

Excipients: ethanol of 96%, glycerin.

Contraindication

Increased individual sensitivity to medicine ingredients. Bronchial asthma and spasm of lungs.

by

For inhalations by the adult till 10-20 drops of Ingalina® to 1 glass (200 ml) of warm water, and to children since 3 years – till 5-10 drops. 3-4 times a day are recommended to carry out inhalations. Duration of a course of treatment is determined by the doctor depending on a condition of sick and clinical effect.

Feature of application

Pregnant

Use of medicine during pregnancy and feeding by a breast perhaps only after assessment by the doctor of a ratio risk/advantage.

not to apply

to children up to 3 years.

Drivers

during treatment of Ingalinom® to the patient needs to refrain from control of vehicles and performance of other work which needs special attention, the speed of mental and motor reactions.

At long application in considerable doses the dizziness, confusion of consciousness, muscle weakness, nausea, doubling in eyes are possible

. In such cases it is necessary to stop administration of drug. Symptomatic therapy.

Side effects

Drug is usually well transferred by

, but there can be allergic reactions, in a particular, in the form of an enanthesis, an itch, sometimes contact dermatitis (in lips), a Quincke's edema, a small tortoiseshell; bronchospasm, laryngospasm, apnoea. At the significant reactions the use of medicine needs to be stopped.

Interaction

For this time the interaction of Ingalina® with other medicines is not revealed by

.

Storage conditions

to Store

in the inaccessible for children, protected from light place at a temperature not above 25 °C.

Expiration date - 3 years.